Factors Associated with Adherence to an End-of-study Biopsy: Lessons from the Prostate Cancer Prevention Trial (SWOG-Coordinated Intergroup Study S9217)

BACKGROUND: The Prostate Cancer Prevention Trial (PCPT) was a 7-year randomized, double-blind, placebo-controlled trial of the efficacy of finasteride for the prevention of prostate cancer with a primary outcome of histologically-determined prevalence of prostate cancer at the end of 7 years. METHOD...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Gritz, Ellen R., Arnold, Kathryn B., Moinpour, Carol M., Burton-Chase, Allison M., Tangen, Catherine M., Probstfield, Jeffrey F., See, William A., Lieber, Michael M., Caggiano, Vincent, Moody-Thomas, Sarah, Szczepanek, Connie, Ryan, Anne, Carlin, Susie, Hill, Shannon, Goodman, Phyllis J., Padberg, Rose Mary, Minasian, Lori M., Meyskens, Frank L., Thompson, Ian M.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2014
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4119542/
https://ncbi.nlm.nih.gov/pubmed/25028457
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1055-9965.EPI-14-0202
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares